1. Home
  2. SRFM vs TMCI Comparison

SRFM vs TMCI Comparison

Compare SRFM & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Surf Air Mobility Inc.

SRFM

Surf Air Mobility Inc.

HOLD

Current Price

$1.16

Market Cap

123.3M

ML Signal

HOLD

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$1.35

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRFM
TMCI
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.3M
120.4M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
SRFM
TMCI
Price
$1.16
$1.35
Analyst Decision
Hold
Hold
Analyst Count
3
6
Target Price
$3.25
$4.77
AVG Volume (30 Days)
2.2M
561.6K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
45.69
N/A
EPS
N/A
N/A
Revenue
$106,557,000.00
$212,690,000.00
Revenue This Year
$25.90
N/A
Revenue Next Year
$20.72
$8.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.59
52 Week Low
$1.04
$1.17
52 Week High
$9.35
$7.78

Technical Indicators

Market Signals
Indicator
SRFM
TMCI
Relative Strength Index (RSI) 31.94 42.28
Support Level $1.04 $1.31
Resistance Level $2.16 $3.01
Average True Range (ATR) 0.10 0.11
MACD 0.01 0.04
Stochastic Oscillator 25.93 59.46

Price Performance

Historical Comparison
SRFM
TMCI

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: